| 英文别名 |
4-Imidazolidinone,5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-;Necrostatin-1;5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one;MTH-DL-TRYPTOPHAN;Necrostatin 1;5-indol-3-ylmethyl-3-methyl-2-thioxo-imidazolidin-4-one;methyl-thiohydantoin-tryptophan;MTH-trp;Nec-1;Necroptotic Inhibitor,Nec-1;5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone;5-(Indol-3-ylmethyl)-3-methyl-2-thio-Hydantoin;5-[(1H-Indol-3-yl)methyl]-3-methyl-2-thioxoimidazolidin-4-one;Necroptotic Inhibitor, Nec-1;5-((1H-indol-3-yl)methyl)-3-methyl-2-thioxoimidazolidin-4-one;AK326153;4-imidazolidinone, 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-;Methylthiohydantoin-DL-tryptophan;MTH-DL-tryptoph;Methylthiohydantoin-DL-tryptophan;MTH-DL-tryptophan;5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylidene-4-imidazolidinone;5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone;Oprea1_645908;s8037;AB00073999-01;EX-A2108;GTPL9750;NECROSTATIN;AKOS023092523;HMS3677G04;HMS3653J04;NCGC00092372-15;SW219795-1;4-Imidazolidinone, 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo- (9CI);NCGC00092372-01;5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone, Nec-1;BDBM36371;HMS3229H21;AKOS001662677;CS-1666;AC-32084;Necrostatin-1 inactive control;BCP06760;HMS3673K15;BRD-A36318220-001-01-3;Q27163481;methylthiohydantoin-DL-tryptophan;CHEMBL195008;CID2828334;NCGC00092372-03;HY-15760;C13H13N3OS;CCG-265032;HMS3268N04;NCGC00092372-02;SCHEMBL856922;MLS006011643;MFCD00056916;CHEBI:91658;5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-imidazolidin-4-one;Necrostatin 1;Necrostatin-1, >=98% (HPLC);SMR001375661;N1174;4311-88-0;A826160;Hydantoin, 5-(indol-3-ylmethyl)-3-methyl-2-thio- (7CI,8CI);DTXSID40385186;AKOS016050497;HMS3413G04;FT-0635218;AS-10165;CBDivE_006695;BRD-A36318220-001-08-8;BRD-A36318220-001-08-8;BRD-A36318220-001-08-8;5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanyl-3,5-dihydro-4H-imidazol-4-one;5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanyl-3,5-dihydro-4H-imidazol-4-one;5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanyl-3,5-dihydro-4H-imidazol-4-one;5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxoimidazolidin-4-one;5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxoimidazolidin-4-one;5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxoimidazolidin-4-one;BRD-A36318220-001-09-6;BRD-A36318220-001-09-6;BRD-A36318220-001-09-6;DB-051029;DB-051029;Nec-1 , Necrostatin 1;DB-051029;Nec-1 , Necrostatin 1;BRD-A36318220-001-11-2;Nec-1 , Necrostatin 1;STL452869;BRD-A36318220-001-11-2;BRD-A36318220-001-11-2;STL511330;STL452869;STL452869;TXUWMXQFNYDOEZ-UHFFFAOYSA-N;STL511330;STL511330;SDCCGSBI-0207171.P004;TXUWMXQFNYDOEZ-UHFFFAOYSA-N;TXUWMXQFNYDOEZ-UHFFFAOYSA-N;DA-66007;SDCCGSBI-0207171.P004;SDCCGSBI-0207171.P004;Necrostatin-1?;DA-66007;DA-66007;Necrostatin-1?;Necrostatin-1? |